PAPER Gandy S
SEARCH RESULTS
330988 RESULTS
PAPER Tsolaki F, Gogaki E, Tiganita S, Skatharoudi C, Lopatatzidi C, Topouzis F, Tsolaki M
Alzheimer's disease and primary open-angle glaucoma: is there a connection?
Clin Ophthalmol. 2011;5:887-90. PubMed: 21760717PAPER Saxena U
Bioenergetics breakdown in Alzheimer's disease: targets for new therapies.
Int J Physiol Pathophysiol Pharmacol. 2011;3(2):133-9. PubMed: 21760971PAPER Moretti DV, Prestia A, Fracassi C, Geroldi C, Binetti G, Rossini PM, Zanetti O, Frisoni GB
Volumetric differences in mapped hippocampal regions correlate with increase of high alpha rhythm in Alzheimer's disease.
Int J Alzheimers Dis. 2011;2011:208218. PubMed: 21760984PAPER Guerra A, Assenza F, Bressi F, Scrascia F, Del Duca M, Ursini F, Vollaro S, Trotta L, Tombini M, Chisari C, Ferreri F
Transcranial magnetic stimulation studies in Alzheimer's disease.
Int J Alzheimers Dis. 2011;2011:263817. PubMed: 21760985PAPER Martinez A, Gil C, Perez DI
Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment.
Int J Alzheimers Dis. 2011;2011:280502. PubMed: 21760986PAPER Zhang Y, Schuff N, Ching C, Tosun D, Zhan W, Nezamzadeh M, Rosen HJ, Kramer JH, Gorno-Tempini ML, Miller BL, Weiner MW
Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer's disease and frontotemporal dementia.
Int J Alzheimers Dis. 2011;2011:546871. PubMed: 21760989PAPER Mevel K, Chételat G, Eustache F, Desgranges B
The default mode network in healthy aging and Alzheimer's disease.
Int J Alzheimers Dis. 2011;2011:535816. PubMed: 21760988PAPER Simakova O, Arispe NJ
Fluorescent analysis of the cell-selective Alzheimer's disease aβ Peptide surface membrane binding: influence of membrane components.
Int J Alzheimers Dis. 2011;2011:917629. PubMed: 21760991PAPER Bucossi S, Mariani S, Ventriglia M, Polimanti R, Gennarelli M, Bonvicini C, Pasqualetti P, Scrascia F, Migliore S, Vernieri F, Rossini PM, Squitti R
Association between the c. 2495 A> G ATP7B Polymorphism and Sporadic Alzheimer's Disease.
Int J Alzheimers Dis. 2011;2011:973692. PubMed: 21760992PAPER Wang D, Yuen EY, Zhou Y, Yan Z, Xiang YK
Amyloid beta peptide-(1-42) induces internalization and degradation of beta2 adrenergic receptors in prefrontal cortical neurons.
J Biol Chem. 2011 Sep 9;286(36):31852-63. PubMed: 21757762PAPER Chen W, Song X, Zhang Y,
Assessment of the Virchow-Robin Spaces in Alzheimer disease, mild cognitive impairment, and normal aging, using high-field MR imaging.
AJNR Am J Neuroradiol. 2011 Sep;32(8):1490-5. PubMed: 21757525PAPER Romi F, Helgeland G, Gilhus NE
Heat-shock proteins in clinical neurology.
Eur Neurol. 2011;66(2):65-9. PubMed: 21757921PAPER Wege N, Dlugaj M, Siegrist J, Dragano N, Erbel R, Jöckel KH, Moebus S, Weimar C,
Population-based distribution and psychometric properties of a short cognitive performance measure in the population-based Heinz Nixdorf Recall Study.
Neuroepidemiology. 2011;37(1):13-20. PubMed: 21757960PAPER Poduslo JF, Hultman KL, Curran GL, Preboske GM, Chamberlain R, Marjańska M, Garwood M, Jack CR, Wengenack TM
Targeting vascular amyloid in arterioles of Alzheimer disease transgenic mice with amyloid β protein antibody-coated nanoparticles.
J Neuropathol Exp Neurol. 2011 Aug;70(8):653-61. PubMed: 21760540Current Filters
No filters selected